NR 508 Week 2 Latest 2023 - 2024

NR 508 Week 2 (Latest 2023 - 2024) New Full Questions and Answers ( Included ) 100% Correct

• Men who use transdermal testosterone gel (AndroGel) should be advised to avoid:
• Washing their hands after applying the gel
• Wearing occlusive clothing while using the gel
• Exposure to estrogens while using the gel
• Skin-to-skin contact with pregnant women while using the gel: 4. Skin-to-skin contact with pregnant

women while using the gel

• Education when prescribing androgens to male patients includes advising that:
• Short-term use places the patient at risk for hepatocellular carcinoma.
• Cholestatic hepatitis and jaundice may occur with low doses of androgens.
• Gynecomastia is a rare occurrence with the use of androgens.
• Low sperm levels only occur with long-term use of androgens.: 2. Cholestatic hepatitis and jaundice

may occur with low doses of androgens.

• Patients who are prescribed exogenous androgens need to be warned that decreased libido:
• Is an unusual side effect of androgens and should be reported to the provider
• Is treated with increased doses of androgens, so the patient should let the provider know if he is

having problems

• May be a sign of early prostate cancer and he should make an appointment for a prostate screening

exam

4. May occur with androgen therapy: 4. May occur with androgen therapy

4. The U.S. Food and Drug Administration warns that androgens may cause:

• Peliosis hepatis
• Orthostatic hypotension
• Menstrual irregularities

4. Acne: 1. Peliosis hepatis

5. Monitoring for a patient who is using androgens includes evaluation of:

• Complete blood count and C-reactive protein levels
• Lipid levels and liver function tests
• Serum potassium and magnesium levels

4. Urine protein and potassium levels: 2. Lipid levels and liver function tests

• Male patients require before and during andro- gen

therapy.

• A digital prostate exam
• A Doppler exam of testicular blood flow
• Urine analysis for proteinuria 1 / 2

4. Serial orthostatic blood pressures: 1. A digital prostate exam

7. Absolute contraindications to estrogen therapy include:

• History of any type of cancer
• Clotting disorders
• History of tension headaches

4. Orthostatic hypotension: 2. Clotting disorders

8. Postmenopausal women with an intact uterus should not be prescribed:

• Estrogen/progesterone combination
• IM medroxyprogesterone (Depo Provera)
• Estrogen alone

4. Androgens: 3. Estrogen alone

• Women who have migraines with an aura should not be prescribed estrogen because of:
• The interaction between triptans and estrogen, limiting migraine therapy choices
• An increased incidence of migraines with the use of estrogen
• An increased risk of stroke occurring with estrogen use
• Patients with migraines may be prescribed estrogen without any concerns-

: 3. An increased risk of stroke occurring with estrogen use

• A 22-year-old woman receives a prescription for oral contraceptives. Edu- cation for this patient

includes:

• Counseling regarding decreasing or not smoking while taking oral contraceptives
• Advising a monthly pregnancy test for the first 3 months she is taking the contraceptive
• Advising that she may miss two pills in a row and not be concerned about pregnancy
• Recommending that her next follow-up visit is in 1 year for a refill and annual exam: 1. Counseling

regarding decreasing or not smoking while taking oral contraceptives

• A 19-year-old female is a nasal Staph aureus carrier and is placed on 5 days of rifampin for treatment.

Her only other medication is combined oral contra- ceptives. What education should she receive regarding her medications?

• Separate the oral ingestion of the rifampin and oral contraceptive by at least an hour.
• Both medications are best tolerated if taken on an empty stomach.
• She should use a back-up method of birth control such as condoms for the rest of the current pill pack.
• If she gets nauseated with the medications she should call the office for an

antiemetic prescription.: 3. She should use a back-up method of birth control such as condoms for the rest of the current pill pack.

• A 56-year-old woman is complaining of vaginal dryness and dyspareunia. To treat her symptoms

with the lowest adverse effects she should be pre- scribed:

• Low-dose oral estrogen
• / 2